Home
Login Register
SingMedical   

Impressive growth in last 3 years

 Post Reply 21-40 of 409
 
CleanNGreen
    25-Nov-2022 12:54  
Contact    Quote!
So they need how many percent to make the offer unconditional?
 
 
ysh2006
    25-Nov-2022 02:59  
Contact    Quote!
Maybe still cannot cross the mandatory take over level that is why they didn't said it in the announcement
 
 
ohm136
    24-Nov-2022 21:11  
Contact    Quote!
Acceptance level as of 6pm today =90.66% (approx) of the total no. of issued shares and 89.26%(approx) of the max. potential no. of issued shares. What is the difference between the 2 types of shares?
 

 
MambaFinancial89
    24-Nov-2022 10:17  
Contact    Quote!
Appears that the 90% threshold will cross, just a few million shares away at this point. 

ysh2006      ( Date: 24-Nov-2022 01:25) Posted:

If don't accept the offer UOB does UOB have another report to say 45c again. ?

 
 
ysh2006
    24-Nov-2022 01:25  
Contact    Quote!
If don't accept the offer UOB does UOB have another report to say 45c again. ?
 
 
MambaFinancial89
    22-Nov-2022 15:37  
Contact    Quote!
UOB released an updated note on 9 November recommending shareholders to accept the offer. 

https://research.uobkayhian.com/content_download.jsp?id=70564& h=1858b599464b97dfb6fba49be61a5fd0

RickyCheng      ( Date: 12-Nov-2022 11:14) Posted:

https://www.theedgesingapore.com/news/offer/smgs-ceo-beng-and-party-raise-takeover-offer-40-cents

UOB Kay Hian&rsquo s Llelleythan Tan, in his  Sept 22 note, urged shareholders to reject the offer. Tan has a target price of 45 cents on the stock.

 

 
ysh2006
    22-Nov-2022 14:33  
Contact    Quote!
This stock still trading in market is the privatisation successful ? Any news from company ?

MoneyUnsavvy      ( Date: 10-Nov-2022 17:15) Posted:

Anyone want to provide any views on the acceptance based on the revised rate? Take it or drop it?
 

 
 
RickyCheng
    12-Nov-2022 11:14  
Contact    Quote!
https://www.theedgesingapore.com/news/offer/smgs-ceo-beng-and-party-raise-takeover-offer-40-cents

UOB Kay Hian&rsquo s Llelleythan Tan, in his  Sept 22 note, urged shareholders to reject the offer. Tan has a target price of 45 cents on the stock.
 
 
MoneyUnsavvy
    10-Nov-2022 17:15  
Contact    Quote!
Anyone want to provide any views on the acceptance based on the revised rate? Take it or drop it?
 
 
 
RickyCheng
    07-Nov-2022 09:25  
Contact    Quote!
Beautiful.  Dun take the retail investors for granted. 
The offeror does not intend to revise the offer, but reserves right to do so in a competitive situation.  Haha.

desmondxyz      ( Date: 03-Nov-2022 10:48) Posted:

We need a competitive bid!!

Joelton      ( Date: 03-Nov-2022 09:29) Posted:

Top execs of Singapore Medical Group bump up offer price to S$0.40 to take company private 
FOLLOWING an offer of S$0.37 per share in cash made in September to take Singapore Medical Group (SMG) private, an investment vehicle owned by the top executives of the company have now raised the offer price to S$0.40 per share or one new share in the offeror.
 
The new offer of represents an increase of approximately 8.1 per cent or S$0.03 over the initial cash consideration of S$0.37, and a premium ranging between 25.4 and 28.6 per cent over the volume-weighted average price per share over the past 12 months, the group noted in a bourse filing on Wednesday (Nov 2).
 
It also represents a premium of approximately 16.8 per cent over the net asset value, and 357.1 per cent over the net tangible asset value per share as of Dec 31, 2021, it added.
 
The offeror does not intend to revise the offer, but reserves right to do so in a competitive situation. Shareholders who have accepted the earlier cash consideration are entitled to the revised final offer price, subject to the offer becoming unconditional, the filing noted.
 
Called TLW Success, the investment vehicle is equally-owned by SMG&rsquo s non-executive chairman Tony Tan Choon Keat, chief executive officer Beng Teck Liang and executive director Wong Seng Weng.
 
The offer has been raised in appreciation of shareholders&rsquo continued support and also in view of the prevailing market conditions and business environment, noted Beng.
 
&ldquo The persistence of an uncertain global and economic environment, coupled with the backdrop of a challenging business landscape within the healthcare industry, continues to underscore the critical need to privatise SMG to provide the company with greater management flexibility to deal with significant macroeconomic and operational headwinds and ensure the long-term competitiveness of the company,&rdquo he said.
 
This increased offer price and related costs will not unduly constrain the operations of the company and it can continue to be managed prudently after the privatisation is successfully achieved, he added.


 

 
ohm136
    03-Nov-2022 18:09  
Contact    Quote!
It is possible, since the name  " Singapore Medical Group" carries great intrinsic value.
 
 
Aeonfcuks
    03-Nov-2022 13:07  
Contact    Quote!
I hope someone comes in with another offer at 0.41 and see if the management will let go of their own shares.
 
 
desmondxyz
    03-Nov-2022 10:48  
Contact    Quote!
We need a competitive bid!!

Joelton      ( Date: 03-Nov-2022 09:29) Posted:

Top execs of Singapore Medical Group bump up offer price to S$0.40 to take company private 
FOLLOWING an offer of S$0.37 per share in cash made in September to take Singapore Medical Group (SMG) private, an investment vehicle owned by the top executives of the company have now raised the offer price to S$0.40 per share or one new share in the offeror.
 
The new offer of represents an increase of approximately 8.1 per cent or S$0.03 over the initial cash consideration of S$0.37, and a premium ranging between 25.4 and 28.6 per cent over the volume-weighted average price per share over the past 12 months, the group noted in a bourse filing on Wednesday (Nov 2).
 
It also represents a premium of approximately 16.8 per cent over the net asset value, and 357.1 per cent over the net tangible asset value per share as of Dec 31, 2021, it added.
 
The offeror does not intend to revise the offer, but reserves right to do so in a competitive situation. Shareholders who have accepted the earlier cash consideration are entitled to the revised final offer price, subject to the offer becoming unconditional, the filing noted.
 
Called TLW Success, the investment vehicle is equally-owned by SMG&rsquo s non-executive chairman Tony Tan Choon Keat, chief executive officer Beng Teck Liang and executive director Wong Seng Weng.
 
The offer has been raised in appreciation of shareholders&rsquo continued support and also in view of the prevailing market conditions and business environment, noted Beng.
 
&ldquo The persistence of an uncertain global and economic environment, coupled with the backdrop of a challenging business landscape within the healthcare industry, continues to underscore the critical need to privatise SMG to provide the company with greater management flexibility to deal with significant macroeconomic and operational headwinds and ensure the long-term competitiveness of the company,&rdquo he said.
 
This increased offer price and related costs will not unduly constrain the operations of the company and it can continue to be managed prudently after the privatisation is successfully achieved, he added.

 
 
Joelton
    03-Nov-2022 09:29  
Contact    Quote!
Top execs of Singapore Medical Group bump up offer price to S$0.40 to take company private 
FOLLOWING an offer of S$0.37 per share in cash made in September to take Singapore Medical Group (SMG) private, an investment vehicle owned by the top executives of the company have now raised the offer price to S$0.40 per share or one new share in the offeror.
 
The new offer of represents an increase of approximately 8.1 per cent or S$0.03 over the initial cash consideration of S$0.37, and a premium ranging between 25.4 and 28.6 per cent over the volume-weighted average price per share over the past 12 months, the group noted in a bourse filing on Wednesday (Nov 2).
 
It also represents a premium of approximately 16.8 per cent over the net asset value, and 357.1 per cent over the net tangible asset value per share as of Dec 31, 2021, it added.
 
The offeror does not intend to revise the offer, but reserves right to do so in a competitive situation. Shareholders who have accepted the earlier cash consideration are entitled to the revised final offer price, subject to the offer becoming unconditional, the filing noted.
 
Called TLW Success, the investment vehicle is equally-owned by SMG&rsquo s non-executive chairman Tony Tan Choon Keat, chief executive officer Beng Teck Liang and executive director Wong Seng Weng.
 
The offer has been raised in appreciation of shareholders&rsquo continued support and also in view of the prevailing market conditions and business environment, noted Beng.
 
&ldquo The persistence of an uncertain global and economic environment, coupled with the backdrop of a challenging business landscape within the healthcare industry, continues to underscore the critical need to privatise SMG to provide the company with greater management flexibility to deal with significant macroeconomic and operational headwinds and ensure the long-term competitiveness of the company,&rdquo he said.
 
This increased offer price and related costs will not unduly constrain the operations of the company and it can continue to be managed prudently after the privatisation is successfully achieved, he added.
 
 
lailai
    03-Nov-2022 08:37  
Contact    Quote!
If offer not successful, drop vely steep, why chase for peanuts, maybe toxic wan.

ysh2006      ( Date: 03-Nov-2022 05:54) Posted:

Don't know the expiry date got extended or not ?

spursfan      ( Date: 02-Nov-2022 21:12) Posted:


For Immediate Release

TLW Success revises the Offer Consideration by raising the Cash
Consideration for each Offer Share in Singapore Medical Group Limited to
S$0.40 as the final offer

https://links.sgx.com/1.0.0/corporate-announcements/XQ8MOYINT9BRGBD8/737382_Press%20Release%20on%20the%20Revision%20of%20Offer%20Consideration.pdf


 

 
ysh2006
    03-Nov-2022 05:54  
Contact    Quote!
Don't know the expiry date got extended or not ?

spursfan      ( Date: 02-Nov-2022 21:12) Posted:


For Immediate Release

TLW Success revises the Offer Consideration by raising the Cash
Consideration for each Offer Share in Singapore Medical Group Limited to
S$0.40 as the final offer

https://links.sgx.com/1.0.0/corporate-announcements/XQ8MOYINT9BRGBD8/737382_Press%20Release%20on%20the%20Revision%20of%20Offer%20Consideration.pdf

 
 
spursfan
    02-Nov-2022 21:12  
Contact    Quote!

For Immediate Release

TLW Success revises the Offer Consideration by raising the Cash
Consideration for each Offer Share in Singapore Medical Group Limited to
S$0.40 as the final offer

https://links.sgx.com/1.0.0/corporate-announcements/XQ8MOYINT9BRGBD8/737382_Press%20Release%20on%20the%20Revision%20of%20Offer%20Consideration.pdf
 
 
MambaFinancial89
    02-Nov-2022 19:28  
Contact    Quote!
If the deal falls through the Offeror will not buy any shares.

CleanNGreen      ( Date: 02-Nov-2022 17:10) Posted:

Anyone knows, if i have already filled in the form to sell the shares to the company, if the privatisaion failed, does the company still buy my shares?

 
 
MambaFinancial89
    02-Nov-2022 19:26  
Contact    Quote!
6 months

Neutral_Guy      ( Date: 02-Nov-2022 16:14) Posted:

Anybody knows if this attempt fail. How long they have to wait if want to call for another privatization?

 
 
CleanNGreen
    02-Nov-2022 17:10  
Contact    Quote!
Anyone knows, if i have already filled in the form to sell the shares to the company, if the privatisaion failed, does the company still buy my shares?
 
Important: Please read our Terms and Conditions and Privacy Policy .